FR19C1073I1 - - Google Patents
Info
- Publication number
- FR19C1073I1 FR19C1073I1 FR19C1073C FR19C1073I1 FR 19C1073 I1 FR19C1073 I1 FR 19C1073I1 FR 19C1073 C FR19C1073 C FR 19C1073C FR 19C1073 I1 FR19C1073 I1 FR 19C1073I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14410699P | 1999-07-16 | 1999-07-16 | |
PCT/EP2000/006917 WO2001005383A2 (en) | 1999-07-16 | 2000-07-17 | Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
Publications (2)
Publication Number | Publication Date |
---|---|
FR19C1073I1 true FR19C1073I1 (no) | 2020-01-17 |
FR19C1073I2 FR19C1073I2 (fr) | 2020-12-18 |
Family
ID=22507065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR19C1073C Active FR19C1073I2 (fr) | 1999-07-16 | 2019-12-09 | Inhibition de l'absorption renale de molecules pouvant potentiellement endommager les reins a l'aide d'une combinaison de lysine et d'arginine |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1196154B1 (no) |
JP (1) | JP2003504395A (no) |
AU (1) | AU6275800A (no) |
CA (1) | CA2379696C (no) |
DE (1) | DE60030722T2 (no) |
FR (1) | FR19C1073I2 (no) |
WO (1) | WO2001005383A2 (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002275059A (ja) * | 2001-03-15 | 2002-09-25 | Inst Of Physical & Chemical Res | 腎機能障害改善用アミノ酸組成物 |
FI20010764A0 (fi) * | 2001-04-11 | 2001-04-11 | Map Medical Technologies Oy | Kationiset dekstraanijohdannaiset käytettäväksi munuaisten suojaamiseen |
US7345018B2 (en) | 2002-04-25 | 2008-03-18 | Reception Aps | Method of treating side effects induced by therapeutic agents |
AU2002307802A1 (en) * | 2002-04-25 | 2003-10-08 | Recepticon Aps | Antagonists of megalin or cubilin for use in preventing organ damage induced by therapeutic agents |
WO2004084953A1 (en) * | 2003-03-24 | 2004-10-07 | Schering Ag | Modulators of the megalin-mediated uptake of radiotherapeutics and/or radiodiagnostics into kidney cells and their use in therapy and diagnostics |
EP1462119A1 (en) * | 2003-03-24 | 2004-09-29 | Schering AG | Modulators of the megalin-mediated uptake of radiotherapeutics and/or radiodiagnostics into kidney cells and their use in therapy and diagnostics |
JP2006199668A (ja) * | 2005-01-24 | 2006-08-03 | Hiroshima Univ | 腎毒性抑制剤として利用できる新規ペプチドおよびこれを用いた腎毒性抑制剤、並びにこれを用いた抗菌製剤 |
EP1862172A1 (en) | 2006-05-31 | 2007-12-05 | BioSynthema Inc. | Combination of amino acid solution and a gelatin for inhibiting renal uptake |
EP2460542A4 (en) * | 2009-07-31 | 2015-02-18 | Riken | ENDOKRINER PANCREAS CELL INDICATOR AND ITS USE |
RU2528414C1 (ru) * | 2013-01-25 | 2014-09-20 | Закрытое Акционерное Общество "Фарм-Синтез" | Циклический октапептид, радиофармацевтическое средство на его основе и способ применения радиофармацевтического средства для получения лекарственных (фармацевтических) средств для лечения новообразований, экспрессирующих соматостатиновые рецепторы |
WO2020224780A1 (en) | 2019-05-08 | 2020-11-12 | ITM Isotopen Technologien München AG | Para-aminohippuric acid (pah) as a renal protective substance |
WO2021117065A1 (en) * | 2019-12-14 | 2021-06-17 | Manu Chaudhary | Formulations of polybasic drugs to reduce multi-organ toxicity |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2066031C (en) * | 1989-09-29 | 2001-02-27 | Mary A. Gray | Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
US5843894A (en) * | 1995-03-21 | 1998-12-01 | Center For Molecular Medicine And Immunology | Methods for reduced renal uptake of antibody fragments |
US5728678A (en) * | 1995-06-06 | 1998-03-17 | Nestec Ltd. | Method and composition for providing nutrition to a renal failure patient |
WO1997046099A1 (en) * | 1996-06-06 | 1997-12-11 | Neorx Corporation | Liver retention clearing agents |
-
2000
- 2000-07-17 EP EP00949378A patent/EP1196154B1/en not_active Expired - Lifetime
- 2000-07-17 CA CA002379696A patent/CA2379696C/en not_active Expired - Lifetime
- 2000-07-17 AU AU62758/00A patent/AU6275800A/en not_active Abandoned
- 2000-07-17 JP JP2001510440A patent/JP2003504395A/ja active Pending
- 2000-07-17 DE DE60030722T patent/DE60030722T2/de not_active Expired - Lifetime
- 2000-07-17 WO PCT/EP2000/006917 patent/WO2001005383A2/en active IP Right Grant
-
2019
- 2019-12-09 FR FR19C1073C patent/FR19C1073I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
DE60030722D1 (de) | 2006-10-26 |
JP2003504395A (ja) | 2003-02-04 |
EP1196154A2 (en) | 2002-04-17 |
FR19C1073I2 (fr) | 2020-12-18 |
CA2379696C (en) | 2009-09-15 |
CA2379696A1 (en) | 2001-01-25 |
WO2001005383A3 (en) | 2001-07-19 |
EP1196154B1 (en) | 2006-09-13 |
AU6275800A (en) | 2001-02-05 |
DE60030722T2 (de) | 2007-09-20 |
WO2001005383A2 (en) | 2001-01-25 |